Cargando…
Multicenter experiences in temporal bone cancer surgery based on 89 cases
OBJECTIVE: To present outcomes of extensive surgery: lateral, subtotal, total petrosectomies in patients with temporal bone invasion resulting from specific primary cancers. STUDY DESIGN: Retrospective case review. SETTING: Four tertiary referral centers. MATERIAL: 89 patients with cancer of the tem...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321293/ https://www.ncbi.nlm.nih.gov/pubmed/28225795 http://dx.doi.org/10.1371/journal.pone.0169399 |
_version_ | 1782509666770616320 |
---|---|
author | Wierzbicka, Małgorzata Niemczyk, Kazimierz Bruzgielewicz, Antoni Durko, Marcin Klatka, Janusz Kopeć, Tomasz Osuch-Wójcikiewicz, Ewa Pietruszewska, Wioletta Szymański, Marcin Szyfter, Witold |
author_facet | Wierzbicka, Małgorzata Niemczyk, Kazimierz Bruzgielewicz, Antoni Durko, Marcin Klatka, Janusz Kopeć, Tomasz Osuch-Wójcikiewicz, Ewa Pietruszewska, Wioletta Szymański, Marcin Szyfter, Witold |
author_sort | Wierzbicka, Małgorzata |
collection | PubMed |
description | OBJECTIVE: To present outcomes of extensive surgery: lateral, subtotal, total petrosectomies in patients with temporal bone invasion resulting from specific primary cancers. STUDY DESIGN: Retrospective case review. SETTING: Four tertiary referral centers. MATERIAL: 89 patients with cancer of the temporal bone treated between January 2006 and December 2010. INTERVENTION: Multidisciplinary team approach including surgical resection, reconstruction, and postoperative radiotherapy. MAIN OUTCOME MEASURE: Disease-specific survival, overall survival. RESULTS: In 27.0% of the patients, relapse was reported, with an average of 6.3 months after surgery; 31 patients (34.8%) died during the follow-up. The average mortality was 22.1 months. Fifty-four patients (58.7%) stayed alive during the time of observation. The average survival time was 42.0 months. The median time of survival with relapse was 12 months (range: 1–51 months). The three-year disease-free rate was 38.0% and the overall survival rate was 58.7%. CONCLUSIONS: Petrosectomy is an effective treatment for malignant temporal bone invasion. The probability of a good outcome was statistically decreased with a high T grade, positive margins, and salvage surgery. Younger age is connected with better prognosis. One of the major tasks remains to improve detection and to shorten the time to diagnosis, keeping in mind that symptoms are insidious and in younger people, the time before diagnosis was longer. |
format | Online Article Text |
id | pubmed-5321293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53212932017-03-09 Multicenter experiences in temporal bone cancer surgery based on 89 cases Wierzbicka, Małgorzata Niemczyk, Kazimierz Bruzgielewicz, Antoni Durko, Marcin Klatka, Janusz Kopeć, Tomasz Osuch-Wójcikiewicz, Ewa Pietruszewska, Wioletta Szymański, Marcin Szyfter, Witold PLoS One Research Article OBJECTIVE: To present outcomes of extensive surgery: lateral, subtotal, total petrosectomies in patients with temporal bone invasion resulting from specific primary cancers. STUDY DESIGN: Retrospective case review. SETTING: Four tertiary referral centers. MATERIAL: 89 patients with cancer of the temporal bone treated between January 2006 and December 2010. INTERVENTION: Multidisciplinary team approach including surgical resection, reconstruction, and postoperative radiotherapy. MAIN OUTCOME MEASURE: Disease-specific survival, overall survival. RESULTS: In 27.0% of the patients, relapse was reported, with an average of 6.3 months after surgery; 31 patients (34.8%) died during the follow-up. The average mortality was 22.1 months. Fifty-four patients (58.7%) stayed alive during the time of observation. The average survival time was 42.0 months. The median time of survival with relapse was 12 months (range: 1–51 months). The three-year disease-free rate was 38.0% and the overall survival rate was 58.7%. CONCLUSIONS: Petrosectomy is an effective treatment for malignant temporal bone invasion. The probability of a good outcome was statistically decreased with a high T grade, positive margins, and salvage surgery. Younger age is connected with better prognosis. One of the major tasks remains to improve detection and to shorten the time to diagnosis, keeping in mind that symptoms are insidious and in younger people, the time before diagnosis was longer. Public Library of Science 2017-02-22 /pmc/articles/PMC5321293/ /pubmed/28225795 http://dx.doi.org/10.1371/journal.pone.0169399 Text en © 2017 Wierzbicka et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Wierzbicka, Małgorzata Niemczyk, Kazimierz Bruzgielewicz, Antoni Durko, Marcin Klatka, Janusz Kopeć, Tomasz Osuch-Wójcikiewicz, Ewa Pietruszewska, Wioletta Szymański, Marcin Szyfter, Witold Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title | Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title_full | Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title_fullStr | Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title_full_unstemmed | Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title_short | Multicenter experiences in temporal bone cancer surgery based on 89 cases |
title_sort | multicenter experiences in temporal bone cancer surgery based on 89 cases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321293/ https://www.ncbi.nlm.nih.gov/pubmed/28225795 http://dx.doi.org/10.1371/journal.pone.0169399 |
work_keys_str_mv | AT wierzbickamałgorzata multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT niemczykkazimierz multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT bruzgielewiczantoni multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT durkomarcin multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT klatkajanusz multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT kopectomasz multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT osuchwojcikiewiczewa multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT pietruszewskawioletta multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT szymanskimarcin multicenterexperiencesintemporalbonecancersurgerybasedon89cases AT szyfterwitold multicenterexperiencesintemporalbonecancersurgerybasedon89cases |